NCT05187312

Brief Summary

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
69mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jan 2022Jan 2032

First Submitted

Initial submission to the registry

December 25, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

January 14, 2022

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2032

Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

10 years

First QC Date

December 25, 2021

Last Update Submit

April 11, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Adverse events

    Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event

    30-days and 60-days post-procedure

  • Diagnostic yield

    Diagnostic yield after tissue sampling

    1-year follow up

Interventions

Endoscopic intervention in the biliary or pancreatic duct

Endoscopic investigation/intervention with ultrasound

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients eligible for endoscopic procedures at Karolinska University Hospital

You may qualify if:

  • Clinical indication for endoscopic intervention/procedure

You may not qualify if:

  • No informed consent
  • Age \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 18146, Sweden

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, plasma, bile, tissue samples

MeSH Terms

Conditions

CholangiocarcinomaPancreatic NeoplasmsCholangitis, Sclerosing

Interventions

Endoscopic Ultrasound-Guided Fine Needle Aspiration

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsDigestive System NeoplasmsNeoplasms by SiteEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesCholangitisBile Duct DiseasesBiliary Tract Diseases

Intervention Hierarchy (Ancestors)

Biopsy, Fine-NeedleBiopsy, NeedleBiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisImage-Guided BiopsySpecimen HandlingUltrasonography, InterventionalUltrasonographyDiagnostic ImagingDiagnostic Techniques, SurgicalSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Erik von Seth, MD, PhD

    Region Stockholm

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erik von Seth, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2021

First Posted

January 11, 2022

Study Start

January 14, 2022

Primary Completion (Estimated)

January 14, 2032

Study Completion (Estimated)

January 14, 2032

Last Updated

April 12, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations